STOCKHOLM, SWEDEN (UroToday.com) - Presented by D Petrylak,1 D Smith,2 L Appleman,3 M Fleming,4 A Hussain,5 R Dreicer,6 AO Sartor,7 N Shore,8 NJ Vogelzang,9 H Youssoufian,10 VA DiPippo,10 N Stambler,10 K Huang,10 RJ Israel10 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
1Yale University, New Haven, CT; 2University of Michigan, Ann Arbor, MI; 3University of Pittsburgh, Pittsburgh, PA; 4Virginia Oncology Associates, Norfolk, VA; 5University of Maryland, Baltimore, MD; 6Cleveland Clinic, Cleveland, OH; 7Tulane University, New Orleans, LA; 8Carolina Urologic Research Center, Myrtle Beach, SC; 9Comprehensive Cancer Centers of Nevada, Las Vegas, NV; 10Progenics Pharmaceuticals, Inc., Tarrytown, NY
Click HERE to listen to Daniel P. Petrylak, MD discuss the key points from this poster